We first investigated the anti-GBM cytotoxicity of Treg cells, CD8 T cells, or both, by co-culturing them with GBM tumor cells in the presence of αPD1 + αGITR or control IgG2a antibodies. This evidence concerns the gene CD8A and neoplasm.